高级检索
当前位置: 首页 > 详情页

Ginsenoside Rg3 induces apoptosis and inhibits proliferation by down-regulating TIGAR in rats with gastric precancerous lesions

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Basic Medical College, Chengdu University of Traditional Chinese Medicine,Chengdu, China [2]Department of Gastrointestinal Surgery, Sichuan CancerHospital, School of Medicine, University of Electronic Science and Technologyof China, Chengdu, China [3]Hospital of Chengdu University of TraditionalChinese Medicine, Chengdu, China [4]Digestive Endoscopy Center,Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu,China [5]Chengdu University of Traditional Chinese Medicine, Chengdu,China [6]Sichuan University West China Hospital Ganzi Hospital, Ganzi, China [7]Department of Chinese Internal Medicine, Hospital of Chengdu Universityof Traditional Chinese Medicine, Chengdu, China [8]TCM Regulating MetabolicDiseases Key Laboratory of Sichuan Province, Hospital of Chengdu Universityof Traditional Chinese Medicine, Chengdu, China
出处:
ISSN:

关键词: Ginsenoside Rg3 Gastric precancerous lesions Apoptosis TP53-induced glycolysis and apoptosis regulator Reactive oxygen species

摘要:
Background Ginsenoside Rg3 (GRg3) is one of the main active ingredients in Chinese ginseng extract and has various biological effects, such as immune-enhancing, antitumour, antiangiogenic, immunomodulatory and anti-inflammatory effects. This study aimed to investigate the therapeutic effect of GRg3 on gastric precancerous lesion (GPL) induced by N-methyl-N '-nitro-N-nitrosoguanidine (MNNG) and the potential mechanism of action. Methods The MNNG-ammonia composite modelling method was used to establish a rat model of GPL. Histopathological changes in the rat gastric mucosa were observed by pathological analysis using haematoxylin-eosin staining to assess the success rate of the composite modelling method. Alcian blue-periodic acid Schiff staining was used to observe intestinal metaplasia in the rat gastric mucosa. Apoptosis was detected in rat gastric mucosal cells by terminal deoxynucleotidyl transferase-mediated dUTP nick end labelling staining. The production level of reactive oxygen species (ROS) was determined by the dihydroethidium fluorescent probe method, and that of TP53-induced glycolysis and apoptosis regulator (TIGAR) protein was determined by immunohistochemical staining and western blotting. The production levels of nicotinamide adenine dinucleotide phosphate (NADP) and glucose-6-phosphate dehydrogenase (G6PDH) were determined by an enzyme-linked immunosorbent assay, and that of glutathione (GSH) was determined by microanalysis. Results GRg3 significantly alleviated the structural disorganization and cellular heteromorphism in the form of epithelial glands in the gastric mucosa of rats with GPL and retarded the progression of the disease. Overexpression of TIGAR and overproduction of NADP, GSH and G6PDH occurred in the gastric mucosal epithelium of rats with GPL, which in turn led to an increase in the ROS concentration. After treatment with GRg3, the expression of TIGAR and production of NADP, GSH G6PDH decreased, causing a further increase in the concentration of ROS in the gastric mucosal epithelium, which in turn induced apoptosis and played a role in inhibiting the abnormal proliferation and differentiation of gastric mucosal epithelial cells. Conclusion Grg3 can induce apoptosis and inhibit cell proliferation in MNNG-induced GPL rats. The mechanism may be related to down-regulating the expression levels of TIGAR and production levels of GSH, NADP and G6PD, and up-regulating the concentration of ROS.

基金:

基金编号: 82174346 81904178 QNXZ2019017 QNXZ2020003 20-Q03 21-Y17 2021-YF05-02284-SN

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 3 区 医学
小类 | 2 区 全科医学与补充医学
最新[2023]版:
大类 | 2 区 医学
小类 | 2 区 全科医学与补充医学
JCR分区:
出版当年[2022]版:
Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE
最新[2023]版:
Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE

影响因子: 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [1]Basic Medical College, Chengdu University of Traditional Chinese Medicine,Chengdu, China
共同第一作者:
通讯作者:
通讯机构: [7]Department of Chinese Internal Medicine, Hospital of Chengdu Universityof Traditional Chinese Medicine, Chengdu, China [8]TCM Regulating MetabolicDiseases Key Laboratory of Sichuan Province, Hospital of Chengdu Universityof Traditional Chinese Medicine, Chengdu, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43377 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号